For Those Curious About How Cellinique Runs the RE2O Treatment
When you research RE2O (RITUO, Re2O), the first questions that come to mind are usually: what exactly is it made of, how solid is the evidence for its effects, and how much does it cost? Yet once you start looking for "so if I actually want to receive this treatment, which clinic offers it and what's the process?" — organized information is surprisingly hard to find. RE2O handles a relatively new category of material derived from human dermal matrix, so understanding the product and running it safely are two separate matters.
This article focuses on how Cellinique, on Dosan-daero in Gangnam, operates RE2O as a signature service. The in-depth science of the ingredients and mechanism, the evidence grade for its effects, specific pricing, and a direct comparison with Rejuran are already covered in separate articles, so we won't repeat them here — instead we'll link to them at the relevant points. If you'd like to understand what RE2O actually is as a treatment first, see our RITUO (Re2O) Skin Booster: Complete Guide; if you'd like to weigh the evidence grade for its effects, see RITUO Effect: Deep Analysis first. (RE2O is the same treatment known domestically as "RITUO.")
Summary
1. RE2O (RITUO) is a skin booster class that replenishes ECM (extracellular matrix) derived from human acellular dermal matrix (hADM) into the dermis. It was originally developed by L&C Bio, supplied domestically by Huons, with the supply agreement concluded on November 18, 2024.
2. This article is not about re-explaining the ingredients, effects, or pricing — it's about how Cellinique operates RE2O as a signature service (suitability assessment, treatment flow, and aftercare). The science, evidence, and costs are linked to existing articles.
3. Whether RE2O is right for you and what kind of changes you can expect vary significantly depending on skin condition, age, and lifestyle patterns. It's not possible to guarantee identical results or a fixed duration, and the specifics are decided during a prior consultation.
1. What Does It Mean to Treat RE2O as "Cellinique's Signature Service"?
There are already well-organized resources on what RE2O is made of and how it works. What Cellinique wants to explore in this article is the question that comes after: "Even with the same product, the experience differs depending on who operates it and how." RE2O handles a human-derived dermal matrix material, so the regulatory and management framework differs from ordinary HA boosters, and the injection site and depth design, plus post-treatment monitoring, influence how the results are perceived. For that reason, Cellinique runs RE2O not as a one-off treatment but as a signature service that connects consultation, design, treatment, and post-treatment checks in one continuous flow.
We're not using the word "signature" to mean "we do it best." That kind of assertion of superiority goes beyond the evidence, and Cellinique views RE2O as one option among several. By signature service, we mean having a consistent set of principles for how we handle this treatment. That looks like: not stating definitively on public pages the figures where the evidence is divided; confirming the precise product standards and suitability during consultation; and having the same medical team follow up on changes continuously. For a treatment like RE2O where you need to observe changes over time, this consistency helps calibrate expectations realistically.
💡 Fact-check ✓
Source: The Bionews (2024.11.18) — coverage of the L&C Bio · Huons supply agreement
- RE2O (Elravie Re2O) is reported as an ECM-replenishment-class skin booster applying human acellular dermal matrix (hADM). Originally developed by L&C Bio, a company specializing in human tissue regeneration, with domestic supply (distribution rights) held by Huons; the supply agreement was concluded on November 18, 2024.
- L&C Bio's patented tissue processing technology, "Alloclean Technology," is described as preserving the tissue's three-dimensional structure while removing the factors that cause cellular and immune rejection.
- The approach is described as "going beyond collagen to also replenish ECM components," with results and perceived effect varying from person to person.
In one line
RE2O is a skin booster that replenishes ECM obtained from human dermal matrix (hADM) into the dermis. Cellinique runs this treatment as a consistent service connecting consultation, design, treatment, and post-treatment checks.
2. If You're Curious About Ingredients, Effects, or Costs — We'll Link You Here
If we restate RE2O's ingredient science and evidence from scratch in this article, the length grows while the accuracy drops. Cellinique has already organized that content with sources, so please pick the topic you'd like to explore in more depth below. The body of this article stays focused solely on "how Cellinique operates RE2O."
| If you're wondering about this | In this article | Link |
|---|---|---|
| What exactly is RE2O (ingredients, mechanism, treatment overview) | Covered briefly and linked out | RITUO (Re2O) Skin Booster: Complete Guide |
| How validated are the effects (clinical, preclinical, marketing evidence grades) | Not asserted; delegated | RITUO Effect: Deep Analysis |
| What's different from Rejuran (ingredient and mechanism comparison) | Direction difference only mentioned | RITUO vs. Rejuran Comparison Guide |
| How is pricing determined (the factors that drive cost) | No specific amount; delegated to consultation | RITUO Price Guide |
To summarize the key point: unlike stimulation-type boosters that prompt the skin to produce collagen on its own, RE2O is a material designed to directly replenish already-formed ECM components into the dermis. That said, the assertion "directly replenishing it makes it unconditionally better" goes beyond the evidence, and which approach suits your skin is reviewed during consultation. The evidence grades and limitations of clinical data are laid out by grade in our RITUO Effect: Deep Analysis.
3. For Whom Does Cellinique Review RE2O Together?
RE2O is not a treatment we recommend to everyone. In consultations, we typically review suitability together with those who describe concerns along these lines. The following is not a list of "definitive criteria" but rather starting points for what we might explore during consultation.
If you have concerns like these
- Those who feel their skin density and texture are not what they used to be
- Those considering approaching the dermal environment itself rather than a hydration-focused booster
- Those who want to fully understand the characteristics and management framework of a human-derived material before deciding
- Those who are considering the treatment within a management plan of observing change over time, rather than expecting a one-time effect
Conversely, if any of the following apply, Cellinique takes a careful, unhurried approach rather than rushing. Please be sure to mention these during your prior consultation.
We proceed cautiously in these cases
- If you are pregnant, breastfeeding, or planning to be
- If there is an active infection or inflammation in the treatment area
- If you are taking anticoagulants, antiplatelet agents, or immunosuppressants
- If you have a history of autoimmune disease
- If you have a history of allergy to anesthetics (such as lidocaine) or the ingredients
If any of the above applies, we first confirm whether the treatment can proceed and, if needed, also guide you through care options in a different direction. Suitability is not a matter of the product's excellence but rather your individual skin and health conditions.
4. The RE2O Treatment Flow at Cellinique
At Cellinique, RE2O is carried out in the following order. Because this treatment handles a human-derived material and the injection design affects how results are perceived, we place emphasis on keeping the process simple and stable.
- Prior consultation + skin assessment — Medical Director Dr. Kim Kun-woo directly reviews skin density, texture, past treatment history, medications, and lifestyle. Whether RE2O is suitable typically becomes clear at this stage. The characteristics of the human-derived material and the consent process are also explained at this point.
- Area and plan design — We review together which areas benefit from ECM replenishment, and the sequencing and combination with other treatments. We don't insist on a single treatment — we also consider designs that sequence treatments with different approaches.
- Recovery and schedule review — We determine the timing of treatment with downtime availability in mind. Because RE2O is a treatment where you observe change over time, schedule design is important.
- Treatment application — Applied to the dermal layer via micro-injection following cream anesthesia. (Injection depth and volume are designed individually to suit the area and condition.)
- Aftercare + next-session guidance — Precautions immediately following treatment, recovery checkpoints, and, if needed, the interval to the next session are communicated separately. The same medical team follows up on changes continuously.
For a more detailed explanation of the treatment steps themselves (downtime, recovery management in general), see our RITUO (Re2O) Skin Booster: Complete Guide. This article focuses on the principles by which Cellinique operates those steps.
💡 One patient's story — Among those receiving it for the first time, some say, "Because I'd heard in advance that changes take time to appear, I wasn't anxious when there wasn't a big difference right after." That said, recovery and change patterns vary widely by individual, so whatever you notice, feel free to contact Cellinique at any time.
5. How Does Cellinique Handle the Fact That This Is a Human-Derived Material?
The biggest difference between RE2O and ordinary boosters is that it uses material derived from donated human tissue (allogeneic). That means the regulatory and management framework is also different from ordinary synthetic or HA fillers. In Korea, this type of human-tissue-derived material is understood to be processed and managed in accordance with the Human Tissue Safety and Management Act (Act on the Safety and Management of Human Tissues), Korea's MFDS oversight framework, and international standards (AATB, etc.) — with tissue banks and processors licensed by MFDS going through donor consent and suitability assessment before processing. This is precisely why Cellinique explains the consent process and material characteristics separately during consultation when handling this material.
That said, the expression "naturally derived, so completely safe with zero risk" is not appropriate. Given the nature of injection treatments, temporary swelling, redness, or bruising can occur, and rarely, nodules, infection, or allergic reactions may be reported. Cellinique discloses these possibilities sufficiently before the treatment and operates with a flow of confirming the recovery process during post-treatment checks. The specific content of the safety management framework for human-tissue-derived materials and the safety signals reported in clinical settings can be found with sources in our RITUO Effect: Deep Analysis.
💡 Fact-check ✓
Sources: Korea MFDS human tissue safety management materials · Korea Health Industry Development Institute (KHIDI) human tissue-related materials
- Human-tissue-derived materials such as hADM are, in Korea, managed in accordance with the Human Tissue Safety and Management Act and international standards (AATB, etc.), with MFDS-licensed tissue banks and processors going through donor consent and suitability assessment before processing, as reported.
- hADM is a human-derived material that has been used in medical fields such as burn care and reconstruction, and donated tissue must pass a suitability assessment including tests for infectious diseases before being processed, as described.
- Side effects, contraindications, and individual variation exist, just as with every treatment; material characteristics and the consent process are recommended to be explained during consultation.
6. Cellinique's Standards When Comparing RE2O With Other Treatments
"Is RE2O better than Rejuran or other skin boosters?" is a question we're asked often. At Cellinique, we don't answer with "one is better." Because the directions of action and the texture of the evidence differ, the right frame is "which care approach suits you." The table below is general guidance for understanding the difference in direction — it is not an assertion of superiority. Individual suitability is decided during consultation.
| Category | RE2O (hADM · ECM replenishment) | Stimulation-type booster | HA glow booster |
|---|---|---|---|
| Core approach | Directly replenishes ECM components | Stimulates skin regeneration and recovery | Supports moisture and the surface |
| Material class | Human allogeneic-derived ECM (hADM) | Varies by ingredient (e.g., PN class) | HA (hyaluronic acid) |
| How change is perceived | Gradual observation over time | Gradual observation over time | Relatively early sense of hydration |
| Recommended number · interval | Varies by area and individual condition, decided during a prior consultation | ||
If you're curious about a direct comparison of Rejuran (PN class) with RE2O, see our RITUO vs. Rejuran Comparison Guide. Cellinique doesn't insist on a single treatment — we also review designs that sequence treatments with different approaches in the right order during consultation.
7. Why Doesn't This Article State Pricing Definitively?
RE2O pricing varies depending on individual skin condition, scope, and plan, and under Korea's Medical Advertising Act there are restrictions on advertising non-covered treatment fees in a definitive manner. For that reason, this article contains no specific amounts like "X-hundred thousand won" or any discount information. Accurate quotes are provided as a matter of principle during a prior consultation. The factors that drive pricing and how to compare rationally are covered separately in our RITUO Price Guide.
8. How Cellinique Operates RE2O
Cellinique is an anti-aging dermatology clinic on Dosan-daero in Gangnam-gu. For treatments like RE2O that handle human-derived materials and where injection design and post-treatment checks influence how results are perceived, we believe that consistent management by the medical team and deep familiarity with the material affect the safety of the treatment.
Medical Director Dr. Kim Kun-woo personally handles everything from the prior consultation through treatment and post-treatment checks. Because this is a treatment whose effects need to be observed over time, having the same medical staff follow up on changes continuously is an advantage for calibrating expectations realistically. The Dosan-daero location also makes follow-up visits and post-treatment checks convenient — which is an asset for treatments like RE2O where you observe changes over time. (For details on qualifications and training history, please ask during consultation.)
Frequently Asked Questions (FAQ)
Q1. Are RE2O and RITUO the same treatment?
Yes, they are the same treatment. RE2O (Re2O) refers to Elravie Re2O, known domestically as "RITUO." It is a skin booster class that replenishes ECM obtained from human acellular dermal matrix (hADM) into the dermis, originally developed by L&C Bio and supplied domestically by Huons. For a detailed guide to the treatment itself, see our RITUO (Re2O) Skin Booster: Complete Guide.
Q2. How is this article different from the other RITUO articles?
This article is not about re-explaining ingredients, effects, or pricing — it focuses on how Cellinique operates RE2O as a signature service (suitability assessment, treatment flow, human-derived material management, and post-treatment checks). In-depth product science, evidence grades, specific pricing, and a Rejuran comparison are each linked to separate articles.
Q3. Who is RE2O suitable for?
We review suitability together with those who are concerned about skin density and texture, or who are considering approaching the dermal environment itself rather than a hydration-focused booster. That said, if you are pregnant or breastfeeding, have an active infection, are taking anticoagulants or immunosuppressants, have a history of autoimmune disease, or have ingredient allergies, we proceed carefully and you must let us know during your prior consultation. Suitability is a matter of your individual skin and health conditions, decided during consultation.
Q4. It's derived from human tissue (allogeneic) — is it safe?
RE2O's core raw material is human acellular dermal matrix (hADM) made by processing donated human skin tissue. In Korea, such materials are understood to be processed and managed in accordance with the Human Tissue Safety and Management Act, Korea's MFDS oversight framework, and international standards (AATB, etc.). That said, we cannot say there is zero risk, so a prior consultation, suitability assessment, and disclosure of possible side effects are needed. Material characteristics and the consent process are explained during consultation; for further detail on safety, see our RITUO Effect: Deep Analysis.
Q5. When can I expect to feel the effect, and how long does it last?
RE2O is not a treatment that is complete right after the procedure — it is guided as a treatment where you observe change gradually over time. The degree of change and how long it lasts vary widely depending on individual skin condition, age, and lifestyle, so it's difficult to guarantee identical results or a fixed duration for everyone. Evidence grades and limitations of clinical data are organized by grade in our RITUO Effect: Deep Analysis.
Q6. Which is better, RE2O or Rejuran?
This is not a question we can answer with "one is better." Because the directions of action (direct ECM replenishment vs. stimulation-type regeneration) and the texture of the evidence differ, the key is not superiority but which approach suits your skin. We also review them in sequence depending on the situation. For a detailed comparison, see our RITUO vs. Rejuran Comparison Guide.
Q7. Can I just come in for a consultation?
Of course. Because RE2O handles a human-derived material and suitability varies by individual condition, we recommend deciding after fully understanding it. Regardless of whether you proceed with the treatment, if you'd like just a consultation, please feel free to reach out at 02-6203-3434 or via KakaoTalk. (Consultation and treatment fees vary by individual condition and design, and are explained during consultation.)
Closing
In one phrase, RE2O (RITUO) is a skin booster with a clear direction of action — replenishing ECM derived from human dermal matrix (hADM) into the dermis. Rather than re-explaining those ingredients and effects, this article focused on how Cellinique operates RE2O as a signature service connecting consultation, design, treatment, and post-treatment checks. What matters is not flowery language, but consistently and safely handling a human-derived material and observing changes together over time.
At Cellinique (Gangnam, Dosan-daero), Medical Director Dr. Kim Kun-woo personally handles everything from the first consultation through treatment and post-treatment checks. If you're curious whether RE2O actually suits your skin and goals, start with a consultation where you can comfortably discuss your skin condition and care goals. You can find the treatment overview in our RITUO (Re2O) Skin Booster: Complete Guide, the evidence analysis in our RITUO Effect: Deep Analysis, the Rejuran comparison in our RITUO vs. Rejuran Comparison Guide, the cost perspective in our RITUO Price Guide, and the common safety standards on our Cellinique Treatment Safety Guide.
Please note
- Individual variation: Results, duration, and suitability differ depending on your individual skin condition, age, and lifestyle, and the same result cannot be guaranteed.
- Possibility of side effects: Treatment carries the possibility of side effects such as temporary erythema and swelling, and there may be contraindications, which are confirmed during a prior consultation.
✅ Fact-check completion report
Because this article takes an operations-perspective approach that does not re-state product science, clinical effects, or pricing and instead delegates those to existing articles, the facts stated definitively in the body are limited to those verified against the following sources:
1. The Bionews (2024.11.18) · Hankyung (2024.11) coverage — L&C Bio (original developer) · Huons (domestic supplier), Elravie Re2O supply agreement (2024.11.18), hADM application · ECM replenishment approach, Alloclean Technology removing factors causing cellular and immune rejection · thebionews.net
2. Korea MFDS human tissue safety management materials · Korea Health Industry Development Institute (KHIDI) — human-tissue-derived materials such as hADM are managed in accordance with the Human Tissue Safety and Management Act · international standards (AATB) by MFDS-licensed tissue banks and processors going through donor consent and suitability assessment · mfds.go.krKey verified items: ✓ RE2O = RITUO (Elravie Re2O) same treatment ✓ hADM · ECM replenishment definition ✓ original developer / supplier · agreement date (2024.11.18) ✓ Human Tissue Safety and Management Act regulatory framework ✓ individual variation · side effects stated. Points not asserted definitively in the body (delegated to existing articles): ① clinical · preclinical evidence grades for effects (→ RITUO Effect: Deep Analysis) ② specific ingredient ratios · precise MFDS licensing classification / number (not confirmed in published primary databases, assertion withheld) ③ long-term duration ④ specific pricing (→ RITUO Price Guide). No U.S. FDA approval language was used.
Medical Disclaimer
This content is intended to provide general health information; individual diagnosis, treatment suitability, and expected outcomes must be decided through a prior consultation with a physician. Every medical treatment carries individual variation and the possibility of side effects.
Cellinique Consultation & Booking
2F & B1, Yeonseung Building, 228 Dosan-daero, Gangnam-gu, Seoul
Phone 02-6203-3434
Hours Mon-Fri 10:00-19:00 / last Saturday of each month 10:00-16:30
